ACUTE MYELOID LEUKEMIA, IN RELAPSE
Clinical trials for ACUTE MYELOID LEUKEMIA, IN RELAPSE explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA, IN RELAPSE trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA, IN RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New targeted therapy shows promise for Hard-to-Treat leukemia
Disease control CompletedThis study tested a drug called GO-203-2C, which targets cancer cells while leaving healthy cells alone, in 33 adults with acute myeloid leukemia (AML) that had come back or not responded to treatment. The goal was to find the safest dose and see if the drug, alone or with anothe…
Matched conditions: ACUTE MYELOID LEUKEMIA, IN RELAPSE
Phase: PHASE1, PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated May 04, 2026 16:23 UTC
-
Experimental pill takes on tough leukemia in early trial
Disease control CompletedThis early-phase study tested an oral drug called KPT-9274 in 16 adults whose acute myeloid leukemia (AML) had returned or not responded to prior treatments. The main goal was to find the safest dose and check for side effects. The study did not aim to cure the disease, but to ga…
Matched conditions: ACUTE MYELOID LEUKEMIA, IN RELAPSE
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC